Wildtypsequenz: Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome

Vaccine efficacy, effectiveness and protection

WHO-Nomenklatur der SARS-CoV-2-Mutanten: Tracking SARS-CoV-2 variants

Bundesregierung beteiligt sich mit 300 Millionen Euro an CureVac

BMBF: Richtlinie für ein Sonderprogramm zur Beschleunigung von Forschung und Entwicklung dringend benötigter Impfstoffe gegen SARS-CoV-2

via archive.org: mRNA-Sequenz von CVnCov, 11868.doc

via archive.org: mRNA-Sequenz von BNT162b2, 11889.doc

laborermittelte Sequenzen von BNT162b2 und mRNA-1273: Assemblies-of-putative-SARS-CoV2-spike-encoding-mRNA-sequences-for-vaccines-BNT-162b2-and-mRNA-1273

MVA-SARS-2-S DZIF COVID-19 vaccine candidate

mRNA based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus neutralizing antibodies and mediates protection in rodents

CVnCov, Phase-1-Studie inkl. Dosistest von 2 µg bis 20 µg: A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults

CureVacs Daten der finalen Analyse der Phase 2b/3-Studie für CVnCoV, den Impfstoffkandidaten der ersten Generation, zeigen Schutzwirkung in Altersgruppe von 18 bis 60 Jahren

CureVac COVID vaccine let-down spotlights mRNA design challenges

mRNA is an endogenous ligand for Toll-like receptor 3

Suppression of RNA Recognition by Toll-likeReceptors - The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells

Patent der Uni Pennsylvania: MODIFIED NUCLEOSIDES,NUCLEOTIDES, AND NUCLEIC ACIDS,AND USES THEREOF

CellScript gewährt Moderna Sublizenz

CellScript gewährt BioNTech Sublizenz

Gram-Scale Chemical Synthesis of Base-Modified Ribonucleoside-5′-O-Triphosphates

1-N-Methyl-Pseudouridine 5'-Triphosphate, 100 mM Solution

N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice

N1-methyl-pseudouridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density

Recognition of viruses by innate immunity

CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2

CureVac-Patent: Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen

Leaky Stop Codons: Evidence of efficient stop codon readthrough in four mammalian genes

Leaky Stop Codons: Features of the formate dehydrogenase mRNA necessary for decoding of the UGA codon as selenocysteine